Newly-developed Tests Achieve 100% Concordance on Superbug Strains from the CDC
BEVERLY, Mass., Jan. 21, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, announced today it has …